We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




US FDA Announces Clearance for New Handheld Bladder Scanner

By MedImaging International staff writers
Posted on 11 Feb 2015
Print article
Image: The SignosRT Scanner (Photo courtesy of Signostics).
Image: The SignosRT Scanner (Photo courtesy of Signostics).
A new, portable handheld ultrasound bladder scanner has received United States Food and Drug Administration (US FDA) 510(k) clearance.

The real-time scanner uses noninvasive, nonionizing ultrasound technology to measure bladder volume. Measuring the bladder volume of a patient with suspected urinary retention problems can prevent unnecessary catheterization and thereby reduce the occurrence of Urinary Tract Infections (UTI), and bring down costs such as those for hospitalization.

The SignosRT Bladder scanner is made by Signostics (Clovelly Park, SA, Australia), and is currently sold in Australia and New Zealand, with plans for a European launch in March 2015. The scanner weighs less than 400 g and is intended for dynamic bladder imaging and accurate bladder volume measurements in trauma care, home nursing, midwifery, urology, palliative care, rehabilitation, and for general medical practice.

The real-time scanner has a dynamic range of approximately 120 sB, and a scanning depth of up to 18 cm. The scanner is used with the SIGVIEWER computer software for synchronizing image and patient data and for exporting images.

Related Links:

Signostics
US FDA


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Portable X-Ray Unit
AJEX240H
Computed Tomography (CT) Scanner
Aquilion Serve SP
Color Doppler Ultrasound System
DRE Crystal 4PX

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.